“…Cytogenetic characteristics include highly recurrent UM SCNAs such as monosomy 3, losses of chromosome arms 1p, 6q, 8p, and 16q, and gains of 1q, 6p, and 8q [ 6 ], with monosomy 3, 8q gain, and 1p loss being the most prognostically unfavorable [ 7 ]. Although the American Joint Committee on Cancer (AJCC) staging of UM does not currently include cytogenetic information and is based only on clinical observations, it has been shown that the addition of these molecular subsets yields a significant improvement in prognostication compared to the AJCC stage alone [ 8 , 9 , 10 , 11 , 12 ]. While FNAB is considered a safe procedure, there remain small risks of retinal detachment, subretinal hemorrhage, and vitreous hemorrhage, sometimes requiring further surgical intervention to repair [ 13 , 14 ].…”